Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
5.61
+0.61 (12.20%)
At close: Dec 20, 2024, 4:00 PM
5.54
-0.07 (-1.25%)
After-hours: Dec 20, 2024, 7:50 PM EST
Sage Therapeutics Employees
Sage Therapeutics had 487 employees as of December 31, 2023. The number of employees decreased by 202 or -29.32% compared to the previous year.
Employees
487
Change (1Y)
-202
Growth (1Y)
-29.32%
Revenue / Employee
$218,478
Profits / Employee
-$693,211
Market Cap
343.18M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Viemed Healthcare | 996 |
AVITA Medical | 207 |
Voyager Therapeutics | 162 |
Rigel Pharmaceuticals | 147 |
Nyxoah | 147 |
Tango Therapeutics | 140 |
Silence Therapeutics | 109 |
enGene Holdings | 33 |
SAGE News
- 25 days ago - Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 4 weeks ago - After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder - Benzinga
- 4 weeks ago - Sage Therapeutics to end Huntington's disease trial after key therapy fails again - Market Watch
- 4 weeks ago - Sage Therapeutics scraps development of rare disease drug after it fails mid-stage study - Reuters
- 4 weeks ago - Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington's Disease - Business Wire
- 7 weeks ago - Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates - Business Wire
- 7 weeks ago - Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE - PRNewsWire